Pharma Mar, S.A. (PMRA.F)
| Previous close | 47.16 |
| Open | 48.10 |
| Bid | 48.90 x N/A |
| Ask | 49.30 x N/A |
| Day's range | 48.10 - 48.10 |
| 52-week range | 26.06 - 48.10 |
| Volume | |
| Avg. volume | 10 |
| Market cap | 853.121M |
| Beta (5Y monthly) | 0.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.65 (1.35%) |
| Ex-dividend date | 12 June 2024 |
| 1y target est | N/A |
- Simply Wall St.
September 2024's Top Growth Picks With High Insider Ownership
As global markets show signs of recovery, with U.S. stocks rebounding and growth stocks outperforming value shares, the focus on companies with strong insider ownership becomes increasingly relevant. High insider ownership often signals confidence in a company's future prospects, making these firms particularly attractive during periods of market optimism and economic adjustments.
- Simply Wall St.
3 Growth Stocks With Insider Ownership Up To 14%
In the midst of a global market recovery, U.S. stocks have shown solid gains, particularly in the technology sector, bolstering hopes for a "soft landing" for the economy. As growth stocks continue to outpace value shares, it's crucial to identify companies with strong insider ownership as this often signals confidence from those closest to the business. When evaluating growth stocks in today's market environment, high insider ownership can be an important indicator of potential success and...
- Simply Wall St.
3 Growth Companies With High Insider Ownership And Up To 23% Revenue Growth
As global markets exhibit mixed signals with the S&P 500 reaching new highs and sectors like technology leading the charge, investors are navigating through a landscape shaped by fluctuating interest rates and economic indicators. In such a market, growth companies with high insider ownership can be particularly compelling, as this combination often signals strong confidence in the company’s future from those who know it best.
